Clearside Biomedical (NASDAQ:CLSD) Upgraded at StockNews.com
StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) from a sell rating to a hold rating in a research note published on Friday. CLSD has been the topic of a number of other research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $4.00 target price on shares of Clearside […]
StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) from a sell rating to a hold rating in a research note published on Friday. CLSD has been the topic of a number of other research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $4.00 target price on shares of Clearside […]
